SIRT1 and breast carcinoma: It was reasonable for us to conclude that lncRNA-PRLB promoted breast cancer cell proliferation, metastasis, and chemoresistance via miR-4766-5p-mediated regulation of SIRT1 signaling, although more clinical samples and further investigations of the exact roles of lncRNA-PRLB in other cancers were required.